BDP1 mRNA expression correlates with ER and PR receptor expression in patients with metastatic breast cancer occurring three-year post-diagnosis (Figure 4A), patients with breast cancer recurring three years post initial diagnosis (Figure 4B) and correlated with death after three years (Figure 4C) and five years (Figure 4D). This evidence concerns the gene BDP1 and breast cancer.